GLOBEMDS

LIVE

Serial Number

99539692

Owner

Fady Alsherbini

Filing Date

Dec 10, 2025

Add to watchlist:

No watchlists yet

+ Create New Watchlist

GLOBEMDS Trademark

Serial Number: 99539692

GLOBEMDS is a trademark filed by Fady Alsherbini on December 10, 2025. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Fady Alsherbini

10501 wood duck lane
Orland Park, IL 60467

Entity Type: 01

Legal Representation

Correspondence Address

Fady Alsherbini

10501 wood duck lane

Orland Park, IL 60467

United States

Trademark Details

Filing Date

December 10, 2025

Registration Date

Not Registered

Goods & Services

Creating an on-line community for Physicians, medical residents and medical students for the purpose of discussion, sharing medical knowledge and exchanging scientific research and breakthroughs

Telemedicine services

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 20, 2026 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 20, 2026 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 20, 2026 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 16, 2026 GNRN

NON-FINAL ACTION E-MAILED

Apr 16, 2026 GNRT

NON-FINAL ACTION WRITTEN

Apr 16, 2026 CNRT

ASSIGNED TO EXAMINER

Apr 14, 2026 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Apr 3, 2026 MDSM

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 3, 2026 NWOS

APPLICATION FILING RECEIPT MAILED

Dec 10, 2025 MAFR

NEW APPLICATION ENTERED

Dec 10, 2025 NWAP

Related Trademarks

More in Same Class

RAECHELLE

DIRECT DIMENSIONS

FLEETOWL

TURBOLOANS

REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE

REVEL CORPORATION AND ITS SUBSIDIARIES REVEAL-THERAPEUTICS, REVEAL-DIAGNOSTICS, REVEAL-INTELLIGENCE, REVEAL-TECHNOLOGIES, REVEAL-CARDIOLOGY, REVEAL-GENETHERAPY, REVEAL-NEURO, REVEAL-INFLAMMATION, REVEAL-ALZHEIMERS, REVELA-LONGEVITY, REVEAL-ANIMALHEALTH, REVEAL-ONCOLOGY, REVEAL-IMMUNOLOGY, REVEAL-IMMUNOLOGY, REVEAL=WOMENSHEALTH, REVEAL-OPTHAMOLOGY, REVEAL-PEDIATRICDISEASES, REVEAL-DISCOVERY, REVEAL-INTELLIGENCE

LARK ENGINEERING RF TECHNOLOGIES